Clinical Trial: Treatment of TNNT1-Myopathy With L-Tyrosine.

Study Status: Terminated
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.

Brief Summary: The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.

Detailed Summary:
Sponsor: Hadassah Medical Organization

Current Primary Outcome: 1. goal attainment score [ Time Frame: 3 month ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hadassah Medical Organization

Dates:
Date Received: July 2, 2013
Date Started: January 2014
Date Completion:
Last Updated: January 13, 2014
Last Verified: January 2014